How Much Did Chemtos Raise?
Funding & Key Investors

Chemtos has successfully secured a significant capital injection, bringing its total funding to $59K. This latest financing round, which contributed $59K in substantial expansion capital, underscores the firm's robust growth trajectory within the specialized chemical synthesis sector. By leveraging this influx of resources, the company is well-positioned to scale its operations and solidify its market presence as a critical provider of high-purity analytical reference standards.

What is Chemtos?

Chemtos
ManufacturingChemicals & Related ProductsBusiness Services

Chemtos operates at the intersection of advanced organic chemistry and regulatory compliance, specializing in the custom synthesis of organic compounds. The company is a recognized leader in the production of certified primary analytical reference standards, with a specific focus on stable labeled APIs and metabolites. Their technical infrastructure supports complex analytical services, including compound certification and recertification, utilizing high-resolution NMR and LC-MS methodologies. By adhering to stringent GLP protocols, Chemtos provides essential infrastructure for pharmaceutical research and development, ensuring that clients receive high-purity compounds backed by comprehensive Certificates of Analysis. This commitment to quality control and precision makes them an indispensable partner for organizations navigating the complexities of drug development and regulatory submission.

How much funding has Chemtos raised?

Chemtos has raised a total of $59K across 1 funding round:

2021

Debt

$59K

Debt (2021): $59K with participation from PPP

Key Investors in Chemtos

PPP

Public-Private Partnership

What's next for Chemtos?

With the recent infusion of capital, Chemtos is poised to accelerate its strategic roadmap, focusing on the expansion of its catalog of certified reference standards and the enhancement of its analytical service capabilities. The company is expected to prioritize investments in advanced instrumentation and talent acquisition to meet the rising demand for high-purity chemical synthesis. As the pharmaceutical industry continues to emphasize rigorous analytical validation, Chemtos is strategically positioned to capture additional market share. Future growth will likely involve scaling production capacity to support global research initiatives, further cementing its role as a cornerstone of the analytical chemistry supply chain. The firm's ability to maintain high-purity standards while scaling operations will be the primary driver of its long-term competitive advantage in the life sciences sector.

See full Chemtos company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingPharmaceuticalsBusiness ServicesResearch & Development
ManufacturingPlastic, Packaging & ContainersRetailFlowers, Gifts & Specialty Stores
FurnitureManufacturing
Industrial Machinery & EquipmentManufacturingAerospace & DefenseAutomotive Parts

Frequently Asked Questions Regarding Chemtos Financial Insights

What are the most recent funding rounds that Chemtos has completed, and what were the funding rounds?
Chemtos has recently completed 1 funding rounds: Debt on Feb 5, 2021.
What is the total amount of funding Chemtos has raised to date?
Chemtos has raised a total of $59K in funding to date.
How many funding rounds has Chemtos completed?
Chemtos has completed 1 funding rounds.
How much funding did Chemtos raise in its most recent funding round?
Chemtos raised $59K in its most recent funding round.
Who are the lead investors in Chemtos's latest funding round?
The lead investor in Chemtos's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Chemtos's history?
The largest funding round in Chemtos's history was $59K.
See more information about Chemtos